Cleveland Biolabs Inc (NASDAQ:CBLI)

2.49
Delayed Data
As of 3:51pm ET
 -0.03 / -1.19%
Today’s Change
2.24
Today|||52-Week Range
4.25
-37.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line35.4K-13.0M-2.6M-9.8M
 
 
 
 
 
Depreciation841.0K140.1K63.5K21.1K
 
 
 
 
 
Total Other Cash Flow-15.9M2.3M-3.3M4.4M
 
 
 
 
 
Funds From Operations-15.0M-10.6M-5.8M-5.5M
 
 
 
 
 
Funds From/For Other Operating Expenses-559.5K1.4M-754.1K1.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-14.5M-12.1M-5.0M-6.6M
 
 
 
 
 
 
InvestingIncrease In Investments-1.4M-16.9M-17.2M-8.6M
 
 
 
 
 
Decrease In Investments1.7M3.6M22.7M12.5M
 
 
 
 
 
Capital Expenditures-20.2K---10.2K-4.4K
 
 
 
 
Fixed Asset Disposal--3.0M198.9K9.0K
 
 
 
 
Other Investing - Uses-2.0M0.000.000.00
 
 
Net Cash Flow Investing-1.8M-10.3M5.7M3.9M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings-4.2M--0.000.00
 
 
Long Term Debt Reduction-83.6K-2.7M0.000.00
 
 
 
Net Proceeds Stock Sale9.7M27.6M540.0K0.00
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing5.2M0.000.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing10.6M24.9M540.0K0.00
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.3M235.6K-190.0K52.3K
 
 
 
 
 
 
Net Change In Cash-5.7M2.6M1.2M-2.7M